| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.33▼ | 6.33▼ | 6.32▲ | 6.35▼ | 6.73▼ |
| MA10 | 6.33▼ | 6.30▲ | 6.28▲ | 6.61▼ | 6.75▼ |
| MA20 | 6.32▲ | 6.29▲ | 6.35▼ | 6.77▼ | 6.96▼ |
| MA50 | 6.29▲ | 6.35▼ | 6.47▼ | 6.78▼ | 6.29▲ |
| MA100 | 6.36▼ | 6.52▼ | 6.73▼ | 7.00▼ | 34.47▼ |
| MA200 | 6.38▼ | 6.75▼ | 6.73▼ | 6.66▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.012▲ | 0.012▲ | -0.073▼ | 0.120▲ |
| RSI | 55.896▲ | 49.499▼ | 45.460▼ | 33.396▼ | 39.110▼ |
| STOCH | 37.500 | 86.954▲ | 55.847 | 12.938▼ | 38.999 |
| WILL %R | -87.500▼ | -18.919▲ | -63.855 | -81.553▼ | -83.478▼ |
| CCI | -66.302 | 66.237 | -1.472 | -116.019▼ | -198.638▼ |
|
Wednesday, November 19, 2025 06:14 AM
Acquisition will expand existing advanced clinical-stage pipeline of amezalpat (PPAR? Antagonist, Phase 3-ready) and TPST-1495 (Dual Ep2/4 Antagonist, Phase 2 start expected near term) ...
|
|
Monday, November 17, 2025 05:20 AM
Biotheryx, Inc., a biopharmaceutical company focused on the discovery and development of first-in-class protein degraders for cancer and inflammatory diseases, today announced the completion of ...
|
|
Friday, November 07, 2025 04:00 PM
Short interest in BlackRock Technology and Private Equity Term Trust (NYSE:BTX) decreased during the last reporting period, falling from 368.95K to 238.46K. This put -% of the company's publicly ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/11/25 | 6.28 | 6.36 | 6.13 | 6.32 | 1,368,793 |
| 20/11/25 | 6.45 | 6.5899 | 6.21 | 6.21 | 1,614,198 |
| 19/11/25 | 6.36 | 6.4785 | 6.36 | 6.38 | 1,102,747 |
| 18/11/25 | 6.51 | 6.51 | 6.26 | 6.38 | 1,570,800 |
| 17/11/25 | 6.57 | 6.67 | 6.425 | 6.48 | 1,042,900 |
| 14/11/25 | 6.49 | 6.683 | 6.46 | 6.63 | 880,400 |
| 13/11/25 | 6.96 | 6.96 | 6.58 | 6.64 | 1,222,479 |
| 12/11/25 | 7.06 | 7.075 | 6.92 | 6.92 | 656,647 |
| 11/11/25 | 7.11 | 7.12 | 7.01 | 7.01 | 766,771 |
| 10/11/25 | 7.02 | 7.16 | 7.02 | 7.14 | 842,402 |
|
|
||||
|
|
||||
|
|